Management of subretinal macular haemorrhages 
with intravitreous injections of tissue 
plasminogen activator and SF6 gas

Abstract

3/4/2003 vol. 105

Original paper

Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas

Online publish date: 2003/06/21

View full text

AMA

. Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas. Klinika Oczna / Acta Ophthalmologica Polonica. 2003;105(3):140-146.

APA

. (2003). Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas. Klinika Oczna / Acta Ophthalmologica Polonica, 105(3), 140-146.

Chicago

. 2003. "Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas". Klinika Oczna / Acta Ophthalmologica Polonica 105 (3): 140-146.

Harvard

. (2003). Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas. Klinika Oczna / Acta Ophthalmologica Polonica, 105(3), pp.140-146.

MLA

. "Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas." Klinika Oczna / Acta Ophthalmologica Polonica, vol. 105, no. 3, 2003, pp. 140-146.

Vancouver

. Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas. Klinika Oczna / Acta Ophthalmologica Polonica. 2003;105(3):140-146.

Abstract

Management of subretinal macular haemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gas

Share

Integrated with

Editorial Policies